Public Companies
Universal Ibogaine Announces Kelburn Reopening Date
Universal Ibogaine Inc.(TSXV:IBO), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it’s…
Universal Ibogaine Inc.(TSXV:IBO), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it’s research and development clinic, the Kelburn Mental Health and Addiction Recovery Center is scheduled to reopen and commence business operations on October 17, 2022 .
“Progress is going remarkably well on the renovations and program development, we have key hires in place, and we are excited to open and start helping people again. We are looking at about 50% of our expanded occupancy when we open the doors again in October as of today. We have a large referral network for clients and the situation with the addiction and opioid crisis is still only getting worse by the day so we will likely be full pretty quickly. We are also quite pleased with the progress we are making on the ibogaine clinical trial process. We will be the first legal ibogaine clinic in Canada. This could be the turning point in the opioid crisis.”
Dr Ian Rabb, Universal Ibogaine Chief Clinics Officer
About Universal Ibogaine Inc
UI is a life sciences company, with a mission to transform addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorder, and ultimately to utilize that protocol globally through planned future licensing agreements. UI is concurrently developing a state of the art holistic addiction treatment protocol at its Kelburn Recovery Centre that, which when paired with the planned ibogaine detox protocol, is intended to revolutionize the way we treat addiction and drastically improve the lives of individuals and families affected by addiction.
Psychedelic Science 2023 Contract Muzzles Speakers: Two Clauses Dictate What Presenters Can and Can’t Say
Compass Pathways Gets Good News On Psilocybin Patent Journey
Tripping Around The World: The Global Legal Landscape of Psychedelics
Rastafari and Psychedelic Medicines
Compass Pathways’ Stock Soars as COMP360 Receives Patent Victory
COLOTECT™ 1.0 awarded MDA Certificate in Malaysia
Candyflipping: New MindMed-Owned Study Looks at Combining MDMA and LSD
Study Shows New Mechanism For How Psychedelics Promote Plasticity
Nirvana Moves Forward With MedSmart Acquisition
Enveric Biosciences Announces Two Poster Presentations at the Canadian Chemistry Conference and Exhibition (CSC 2023)
-
LSD15 hours agoCannabis Coalition Forms To Push Biden On Federal Reform: Will It Work This Time?
-
LSD15 hours ago
Study Shows New Mechanism For How Psychedelics Promote Plasticity
-
Public Companies14 hours ago
Nirvana Moves Forward With MedSmart Acquisition
-
Psilocybin13 hours ago
Enveric Biosciences Announces Two Poster Presentations at the Canadian Chemistry Conference and Exhibition (CSC 2023)
-
Markets & Investing13 hours ago
Psychedelics in Dubai: Therapeutic Role of Psychedelics Explored at Conference in the Arab Region
-
Psilocybin5 hours agoOregon Pioneers New Psilocybin Business Models
-
Markets & Investing3 hours agoThe 7 Most Promising Penny Stocks to Buy in June